Graft‐Versus‐Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell‐Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations

By  

STEM CELLS, Vol. 36, Iss. 3, 2018-03 ,pp. : 434-445

John Wiley & Sons Inc

Access to resources Recommend Favorite

Wharton’s Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease

By McGuirk Joseph P.   Smith J. Robert   Divine Clint L.   Zuniga Micheal   Weiss Mark L.  

Pharmaceuticals, Vol. 8, Iss. 2, 2015-04 ,pp. : 196-220

MDPI

Access to resources Recommend Favorite

The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease

By Kordelas Lambros   Steckel Nina-Kristin   Horn Peter A.   Beelen Dietrich W.   Rebmann Vera  

International Journal of Molecular Sciences, Vol. 17, Iss. 11, 2016-10 ,pp. : 1797-1797

MDPI

Access to resources Recommend Favorite

T-Cell Manipulation Strategies to Prevent Graft-Versus-Host Disease in Haploidentical Stem Cell Transplantation

By Vadakekolathu Jayakumar   Rutella Sergio  

Biomedicines, Vol. 5, Iss. 2, 2017-06 ,pp. : 33-33

MDPI

Access to resources Recommend Favorite

HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation

By Clausen Johannes   Böhm Alexandra   Straßl Irene   Stiefel Olga   Buxhofer-Ausch Veronika   Machherndl-Spandl Sigrid   König Josef   Schmidt Stefan   Steitzer Hansjörg   Danzer Martin   Kasparu Hedwig   Weltermann Ansgar   Nachbaur David  

Biomedicines, Vol. 5, Iss. 2, 2017-03 ,pp. : 13-13

MDPI

Access to resources Recommend Favorite